Cite
MLA Citation
Mhairi Copland et al.. “Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial.” Lancet, vol. 9, no. 2, 2022, pp. e121–e132. http://access.bl.uk/ark:/81055/vdc_100150530190.0x000005